Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Hypertension & Vascular Disease Scores
Interactive worksheet5 clinical inputsPatient data not stored

ESH Cardiovascular Risk Stratification Calculator

ESH Cardiovascular Risk Stratification: Explanation and Clinical Context The ESH/ESC Cardiovascular Risk Stratification tool is designed to estimate the total cardiovascular risk in hypertensive patients by integrating blood pressure grade, major risk factors (smoking, diabetes, dyslipidemia, age), subclinical organ damage, and established cardiovascular or renal disease. Patients are categorized into Low, Moderate,

Interactive worksheet

Clinical inputs

0/5 filled
Major Cardiovascular Risk Factors (Check all that apply)
Subclinical Organ Damage (Check all that apply)
Established Cardiovascular or Renal Disease (Check all that apply)
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

ESH Cardiovascular Risk Stratification: Explanation and Clinical Context The ESH/ESC Cardiovascular Risk Stratification tool is designed to estimate the total cardiovascular risk in hypertensive patients by integrating blood pressure grade, major risk factors (smoking, diabetes, dyslipidemia, age), subclinical organ damage, and established cardiovascular or renal disease. Patients are categorized into Low, Moderate, High, or Very High Risk based on this combination. High-risk patients benefit from more intensive blood pressure management and consideration of additional preventive therapies, whereas low-risk patients may be managed with lifestyle modifications and standard BP control.

This stratification facilitates personalized treatment planning, prioritizes interventions for patients at greatest risk, and aligns with guideline recommendations for cardiovascular risk management in hypertension.

Evidence & references1 primary source mapped
  1. Source 1

    Williams B, Mancia G, Spiering W, et al. 2023 ESC/ESH Guidelines for the Management of Arterial Hypertension. Eur Heart J. 2023;44:3227–3330. doi:10.1093/eurheartj/ehad153 Mancia G, Fagard R, Narkiewicz K, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104.

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

Pulse Pressure Index (PPI) Calculator

Hypertension & Vascular Disease Scores
Interactive worksheet

White Coat Hypertension Risk Index Calculator

Hypertension & Vascular Disease Scores
Interactive worksheet

SCORE-Hyper Calculator

Hypertension & Vascular Disease Scores
Interactive worksheet

Resistant Hypertension Predictive Score Calculator

Hypertension & Vascular Disease Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.